Abstract
INTRODUCTION: Rapid ascent to altitudes of over 5,000m above sea level are associated with dramatic changes in adaptive physiology. We describe the effects of a more gradual ascent on symptoms, oximetry and heart rate, and compare this approach to the effects of a more rapid ascent to the same altitude by a comparable cohort.
METHODS: A group of 13 (6 females) representing 10 countries from 5 continents, ascended gradually from Lukla (2,300m) to Everest Base Camp (5,300m) in Nepal over an 8-day period, then descended over a further 4 days. We recorded all symptoms, and medication used, along with pulse oximetry and heart rate (HR) every 500m of ascent. We compared results with those obtained at equivalent altitudes using similar methodology from a fast ascent of Mount Kilimanjaro to an equivalent altitude by a comparable cohort over 4 days.
RESULTS: Our group had a median age of 33 years (range 25-66), and all successfully completed the trek. No severe headache, vomiting, orthopnoea nor productive cough occurred, although minor nausea and mild headache was common. Baseline oximetry fell from a median of 96% (93-97%) to a median of 78% (53-86%) at 8 days but recovered to 94% (89-99%) inside 4 days. Corresponding HR rose from a baseline median of 72bpm (57-85) to a median of 103bpm (78-115) at 8 days, then recovered to 80bpm (54-94) after 4 days. Neither age nor gender correlated with outcomes. Individually, HR correlated inversely with oximetry, but we found no group correlation between these two variables. By contrast, a more rapid 4-day ascent from the same starting height, with similar baseline values for HR and oximetry, to the same final altitude was associated with more severe headache, breathlessness, and vomiting. The fast ascent was associated with a more marked reduction in oximetry to a median of 71% (52-76) and an increase in HR to a median of 110bpm (88-140). The fast ascent group also required significantly more medication and rated their experience as less enjoyable.
DISCUSSION: Oxygen desaturation and tachycardia are inevitable consequences of ascending above 5,000m but the degree to which this occurs can be reduced by slowing ascent times and taking rest days every 1,000m of ascent. This practice is associated with fewer symptoms and greater safety, with less need for either prophylactic or therapeutic medication. Careful consideration should be given to rates of ascent when climbing to altitudes at or above 5,000m.
Reference50 articles.
1. Johnson C, Anderson S, Dallimore J, Winser S, Warrell D. Oxford Handbook of expedition and wilderness medicine. Oxford University Press. p618 ISBN 978-0-19-929661-3
2. Grocott, M; Martin, DS.; Levett, D; McMorrow, R; Windsor, J; Montgomery, H. (2009). Arterial Blood Gases and Oxygen Content in Climbers on Mount Everest. N Engl J Med. 360 (2): 140–9. doi:10.1056/NEJMoa0801581. PMID 19129527
3. Cymerman, A; Rock, PB. Medical Problems in High Mountain Environments. A Handbook for Medical Officers (Report). Vol. USARIEM-TN94-2. US Army Research Inst. of Environmental Medicine Thermal and Mountain Medicine Division Technical Report.
4. Young, AJ; Reeves, JT. (2002). Human Adaptation to High Terrestrial Altitude (PDF). Medical Aspects of Harsh Environments. Vol. 2. Borden Institute, Washington, DC. CiteSeerX 10.1.1.175.3270.
5. Bärtsch, P; Gibbs, JSR (2007). Effect of Altitude on the Heart and the Lungs. Circulation. 116 (19): 2191–2202. doi:10.1161/CIRCULATIONAHA.106.650796. PMID 17984389.